NeoRx Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
NeoRx Corporation - overview
Established
2007
Location
Seattle, WA, US
Primary Industry
Biotechnology
About
Founded in 2007, Based in Washington, US, NeoRx Corporation, formerly known as Poniard Pharmaceuticals, Inc. , operates as a biopharmaceutical company that focuses on the development and commercialization of innovative oncology products like Picoplatin, a platinum-based chemotherapeutic agent used for multiple cancer indications, treatment combinations and by two routes of administration.
Current Investors
Abingworth, T Rowe Price, Bay City Capital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Verticals
HealthTech
Total Amount Raised
Subscriber access only
NeoRx Corporation - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PIPE | Completed | NeoRx Corporation | - | ||||||||
| Unspecified Exit | Completed | NeoRx Corporation | - |
Displaying 1 - 2 of 2
NeoRx Corporation - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.